Thromboprophylaxis in Pregnant Women in Hospital: A Prospective Clinical Trial
Thrombophilia Associated With Pregnancy, Perioperative/Postoperative Complications, Venous Thrombosis
About this trial
This is an interventional prevention trial for Thrombophilia Associated With Pregnancy focused on measuring thrombophilia, thrombosis, Pregnancy, High-Risk, venous thrombosis, enoxaparin, risk assessment, deep vein thrombosis, pulmonary embolism, hospitalization
Eligibility Criteria
Inclusion Criteria:
- All pregnant women hospitalized.
Exclusion Criteria:
- Previous use of anticoagulation
Sites / Locations
- University of Sao Paulo General Hospital
Arms of the Study
Arm 1
Arm 2
Other
Other
enoxaparin
no intervention
A prospective study that will evaluate all pregnant women admitted for clinical treatment and / or surgery through the application of a thromboprophylaxis protocol with risk assessment score.The patient in whom prophylaxis would be indicated are those with scores greater than or equal to 3. The drug to be used is enoxaparin and the dose to be used depends on the weight of the patient.It will be further assessed: adverse effects of treatment with enoxaparin, protocol failure in the group treated and untreated (without anticoagulation) and bleeding incidence in both groups.
Pregnant women admitted in hospital for clinical treatment and/or delivery and that does not score for thromboprophylaxis.